Zealthy and infertility in India

The average infertility rate in Indian married couples is around 10-15% Of which only 45% visit a doctor for help and a mere 1% receive infertility treatments. Zealthy is deciding to change how women deal with reproductive health.

Infertility is a problem that globally affects around 15% of all reproductive-age couples. The World Health Organisation (WHO) says that the prevalence of primary infertility in India is between 3.9 to 16.8%. A research conducted by Inito, a Bengaluru-based firm, claims that the average infertility rate in Indian married couples is around 10-15% Within such couples, only 45% visit a doctor for help and a mere 1% receive infertility treatments. A majority of couples rely on homemade remedies and other options that are not clinically proven. 

A huge reason is that there is a lack of awareness in women regarding their reproductive health. To bridge this gap, Akhil Gupta and Rishi Malhotra founded Zealthy in 2018. Zealthy is a health company dedicated to helping women make informed decisions regarding their reproductive health, in areas like fertility and pregnancy. Their offerings are FSSAI and ISO approved and clinically proven. 

The Banglore-based startup offers services and support even for period-related problems like menopause, PCOS (Polycystic Ovary Syndrome) and other conditions. They also provide treatments like IVF, IUI, Surrogacy, Laparoscopy and Hysteroscopy. 

They have partnered with 150+ healthcare players including Apollo Cradle, Milann, Morpheus, Motherhood, and other maternity homes. Since its inception, they have helped over 10,000 mothers with pregnancy. They are currently present in 50+ cities and aim to establish themselves in 150 cities. Zealthy’s parent company, Zuddy Healthtech has raised an undisclosed amount from KYT Ventures, First Cheque, AngelList and other angel investors like MPL’s Shubham Malhotra and former SoftBank director Pavan Ongole. 

The company was generating 5x revenue in August 2020 and they plan to reach Rs 1 crore per month in the coming days and enter tier 2 and tier 3 cities. They also want to expand from English and Hindi into regional languages like Bengali, Tamil, Telugu and Malayalam.

Will Zealthy be able to show growth despite severe competition in the women health segment from Healofy and BabyChakra and even in the women-based e-commerce space with competitors like Nua, PeeSafe, Azah and others?

Tags : #Zealthy #AkhilGupta #RishiMalhotra #womenreproductivehealth #infertility #pregnancy #infertilitytreatments #MediSpeak #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026